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Purpose: Optimal duration of postoperative duplex surveillance ofinfrainguinal vein grafts 
is not known. Previous reports have suggested nearly all vein graft stenoses are present 
within the first postoperative y ar, and normal duplex examination results during this time 
eliminate the need for ongoing graft surveillance. To determine whether surveillance may 
be safely discontinued in patients with normal early postoperative surveillance studies, we 
reviewed the color-flow surveillance xaminations in our patients who underwent 
infrainguinal reverse vein graft revisions during a 41/2 year period. 
IVicthods: Clinical and vascular laboratory records were reviewed of all patients who 
underwent infrainguinal reverse vein bypass grafting followed by subsequent graft revision 
for a duplex scanning-detected abnormality at our institution between January 1990 and 
July 1994. 
Results: Of 447 infrainguinal reverse vein bypasses performed, 36 (8.1%) underwent 
surgical revision as a result of an abnormal finding during routine duplex surveillance. The 
initial postoperative duplex examination was obtained within 2 weeks of graft implanta- 
tion in 23 (64%) patients, between 2 weeks and 3 months in 10 (28%) patients, and 
between 3 and 6 months in three (8%) patients. Duplex abnormalities prompting revision 
included 11 (31%) grafts with a mid-graft peak systolic velocity (PSV) _< 45 cm/sec, 23 
(64%) grafts with a focal PSV -> 200 cm/sec, one graft with a PSV -> 150 cm/sec but < 200 
cm/sec, and one thought to be occluded by duplex but found to be patent by angiography. 
Abnormal duplex findings were initially detected within 2 weeks of graft implantation i
five (14%) patients, between 2 weeks and 3 months in eight (22%) patients, from 3 to 6 
months in 12 (33%) patients, from 6 to 12 months in six (17%) patients, and > i year in 
five (14%) patients. In only 25% of cases were mid-graft PSVs <45 cm/sec or focal 
velocities _> 200 cm/sec identified on the initial examination; 75% were found during 
subsequent surveillance. 
Conclusions: Although most reverse vein graft abnormalities detected by duplex surveil- 
lance and prompting raft revision appear within the first postoperative y ar, many are not 
detected on the initial examination. In our recent experience 31% of duplex abnormalities 
leading to vein graft revision were first detected more than 6 months after operation. 
Discontinuation of graft surveillance based on normal early findings will result in 
thrombosis of some vein grafts that may otherwise be salvaged. (J VAsc SvR~ 
1995;22:476-84.) 
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Infrainguinal vein graft failure results primarily 
from stenotic lesions in the vein graft or from 
progression of disease in the inflow or outflow 
arteries. 14 An estimated 20% to 37% of all infrain- 
guinal vein bypass grafts develop graft-threatening 
lesions within 2 years. 5-7 The ability of  duplex graft 
surveillance to detect hese lesions before they result 
in graft thrombosis is well documented. 8~13 
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The optimal duration of postoperative duplex 
surveillance of an infrainguinal vein graft is not 
known. It is generally accepted that most vein graft 
stenoses develop within 2 years after operation. 2,14,15 
However, recently authors have suggested that al- 
most all vein graft lesions are detectable in the early 
postoperative period and that less intensive duplex 
surveillance or even discontinuation of surveillance 
may be justified, if early studies do not reveal a graft 
abnormality. 16,17 This approach assumes that early 
examinations are 100% specific in excluding the 
discovery of future abnormalities and that vein grafts 
do not become occluded if results of early duplex 
surveillance studies are normal. To evaluate whether 
early, normal, postoperative duplex surveillance x- 
amination results preclude the need for late graft 
revision, we reviewed the duplex surveillance findings 
in our patients who underwent revision of infraln- 
guinal vein grafts to maintain patency. 
MATERIAL AND METHODS 
All patients who underwent both placement of an 
infrainguinal reverse vein bypass and subsequent 
graft revision because of abnormal findings on duplex 
surveillance examinations at either the Oregon 
Health Sciences University Hospital or Department 
of Veterans Affairs Medical Center in Portland, 
Oregon, between January 1990 and July 1994 were 
identified through our computerized vascular surgery 
registry. Only patients whose graft revision was 
prompted by findings on routine duplex surveillance 
were included in this study. 
During this time vein grafts at our institution 
were monitored with a surveillance program based 
on color flow duplex examination of the vein graft at 
3 monthly intervals for i year and 6 monthly intervals 
thereafter. All duplex examinations were performed 
by registered vascular technologists with an Acuson 
XP-128 color flow duplex scanner (Acuson Inc, 
Mountain View, Calif.). Attempts were made to 
visualize and insonate the entire graft, its proximal 
and distal anastomotic sites, and the adjacent inflow 
and outflow arteries. When surveillance xamina- 
tions revealed a mid-graft peak systolic velocity 
(PSV) _< 45 cm/sec or a focal PSV _ 200 cm/sec, 
angiography was performed inspite of the absence of 
symptoms or drop in ankle/brachial index (ABI). 
Although some authors prefer velocity ratios for 
detecting raft abnormalities, 9,n we prefer both an 
absolute high- and low-velocity criteria, which has 
previously been shown to be highly sensitive in 
detecting > 50% diameter reduction in our vascular 
laboratory. 18'~9 If the angiogram confirmed the 
presence of a stenotic lesion with > 50% diameter 
reduction, vein graft revision was performed. 
Each patient's record was reviewed for the 
indication for the initial bypass procedure, its proxi- 
mal and distal anastomotic sites, and the conduit 
used. The vascular laboratory record was reviewed to 
determine the time of the initial postoperative duplex 
surveillance examination, allsubsequent duplex find- 
ings, and spedfically the timing of the duplex finding 
that led to graft revision. Duplex findings were also 
correlated with patient symptoms (increasing dau- 
dication, ischemic rest pain, or new ulceration) and 
with a change in ABI __ 0.2. 
RESULTS 
Patients. Between January 1990 and July 1994, 
447 infrainguinal bypass operations were performed 
at our institution. Thirty-six (8.1%) of these grafts 
underwent surgical revision as a direct result of an 
abnormal color flow duplex surveillance examination. 
Thirty-one (86%) men and five (14%) women with 
a mean age of 66.1 years (range 43 to 86 years) were 
studied. 
Initial bypass. The original indication for infrain- 
guinal reverse vein bypass was claudication i  seven 
patients, ischemic rest pain in 18 patients, and 
ulceration or gangrene in 11 patients. The proximal 
anastomotic site was the common femoral artery in 
seven (19%) patients, the superficial femoral artery in 
14 (39%) patients, and the deep femoral artery in 15 
(42%) patients. The distal anastomotic site was the 
above-knee popliteal artery in three (8%) patients, 
the below-knee popliteal artery in 24 (67%) patients, 
and a tibial artery in nine (25%) patients. Thirty-one 
(86%) of 36 grafts consisted of a single reverse 
greater saphenous vein segment. Alternative conduits 
included a single-arm vein segment in one patient, 
composite arm vein segments in three patients, and 
composite prosthetic-greater saphenous vein in one 
patient who subsequently had a duplex abnormality 
in the venous portion of the graft. 
Duplex surveillance. The average time from 
infrainguinal bypass to first duplex surveillance evalu- 
ation was 1.3 months (range 1 week to 5.8 months). 
Ninety-two percent of the initial duplex evaluations 
were obtained within 3 months of the bypass 
operation, with most (64%) performed within 2 
weeks of graft implantation No intraoperative du- 
plex studies were performed. 
Duplex findings prompting angiography and 
graft revision included 11 (31%) grafts with a low 
mid-graft PSV ( <_ 45 cm/sec), 23 (64%) grafts with 
an increased focal PSV (---200 cm/sec), one graft 
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Fig. 1. Timing of detection for duplex findings that led to surgical revision in 36patients. 
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Fig. 2. Initial duplex velocity in location of 23 vein grafts that were subsequently revised for 
PSV - 200 cm/sec. 
with a moderate focal increase in PSV ( -> 150 cm/sec, 
but < 200 cm/sec), and one thought o be occluded 
by duplex surveillance but found to be patent by 
angiography. 
The average time from infrainguinal bypass to the 
development of the duplex abnormality leading to 
graft revision was 5.8 months (range 1 week to 22 
months). Duplex findings leading to graft revision 
were first detected within 2 weeks of graft implan- 
tation in five (14%) patients, between 2 weeks and 3 
months in eight (22%) patients, from 3 to 6 months 
in 12 (33%) patients, from 6 to 12 months in six 
(17%) patients, and > 1 year in five (14%) patients 
(Fig. 1). Only nine (25%) duplex findings leading to 
graft revision were discovered on the initial duplex 
examination, and 27 (75%) were found during 
subsequent surveillance. 
For the 23 patients in whom a focal PSV --- 200 
cm/sec led to graft revision, the mean PSV obtained 
immediately before angiography and graft revision 
were performed was 347 _+ 113 cm/sec (range 202 
cm/sec to 642 cm/sec). Six (26%) of these patients 
had a PSV -> 200 cm/sec on the initial surveillance 
examination; 74% of the grafts on their initial duplex 
examination had a PSV < 200 cm/sec in the area that 
subsequently developed a focal PSV --200 cm/sec 
(Fig. 2). 
Clinical correlation. At the time the duplex 
abnormality leading to revision was detected, a 
decrease inABI of -> 0.2 was found in only 11 (31%) 
of 36 extremities. Twenty-five (69%) patients were 
asymptomatic, five (14%) had mild clandication, and 
six (16%) had either persistent or recurrent ischemic 
rest pain or ulceration. In all six of the patients with 
rest pain or ulceration, graft lesions were detected 
within 3 months of the initial bypass. 
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Table I. Correlation of duplex surveillance abnormality leading to angiography and operation in 36 
patients undergoing revision of an infrainguinal reverse vein graft or its inflow or outflow artery 
Location of stenosis by angiography 
Duplex surveillance 
abnormality Proximal Proximal Mid Distal Distal Total 
prompting revision Inflow anastomosis graft graft graft anastomosis Ou~low Occluded (%) 
MID PSV <45 cm/sec 1 1 5 2 2 I1 (30.5) 
Focal PSV >200 cm/sec 6 5 7 2 1 1 1 23 (63.9) 
PSV 150-200 cm/sec 1 I (2.7) 
Pseudoocclusion 1 I (2.7) 
Total (%) 1 (2.7) 9 (25.0) 1---6 (27.8) 7 (19.4) 4 (11.1) f (2.7) 3 (8.3) i (2.7) 36 
Angiographic orrelation. Prerevision anglo- 
gram confirmed the presence of a stenosis in the graft 
or an adjacent inflow/outflow artery in aH cases. The 
stenosis was -> 70% in 31 (86%) of the 36 grafts and 
_ 60% in all of the grafts. 
Table I shows the location of the stenotic lesions 
identified by angiography and their correlation to the 
duplex surveillance finding immediately before angi- 
ography. The most frequently encountered lesion 
was an isolated intrinsic graft stenosis, accounting for 
21 (58%) of the lesions, followed by 10 (28%) anas- 
tomotic lesions and four (11%) inflow/outflow ab- 
normalities. One graft occluded by angiography had 
been previously patent on duplex surveillance with a 
PSV -> 200 cm/sec at the proximal anastomosis. 
Of the 11 grafts that underwent angiography and 
revision based on duplex findings of a mid-graft PSV 
___ 45 cm/sec, six (55%) had an angiographic stenosis 
at the proximal anastomosis or in the proximal graft. 
In all six of these grafts the proximal anastomosis was 
to the deep femoral artery of an anatomically 
tunnelled reverse vein bypass. Of the remaining five 
grafts revised based on a mid-graft PSV ___ 45 cm/sec, 
three had stenoses in the inflow or outflow arteries, 
and only two had a stenotic lesion in the graft itself. 
Late graft stenosis. Beyond the first postopera- 
tive year, five (14%) vein grafts developed uplex 
findings that led to graft revision. Four of the five 
patients were asymptomatic at the time the duplex 
finding was first detected. Three of these grafts had a 
focal PSV ---200 cm/sec with stenotic lesions con- 
firmed by angiography in the proximal graft (one), 
the mid-graft (one), and at the distal anastomosis 
(one). In the other two grafts a mid-graft PSV --- 45 
cm/sec led to angiography and revision. A stenotic 
lesion was found in the inflow artery in one of these 
grafts and at the proximal anastomosis in the other. 
Between four and six duplex evaluations (average 
4.6) were performed on each of these five grafts 
before the detection of a duplex velocity that sug- 
gested a stenotic lesion. None of these previous 
duplex evaluations had suggested a low-grade steno- 
sis that progressed with time. 
DISCUSSION 
In 1973 Szilagyi ct al. 1 reported 377 infralnguinal 
vein grafts evaluated prospectively with annual angi- 
ography. In this classic study 33% of all patent 
bypasses developed some intrinsic structural defect, 
usually within 2 years of initial operation. The 
observation that most stenotic lesions showed pro- 
gression of stenosis leading to graft occlusion estab- 
fished the association of graft stenosis with graft 
failure. More recently numerous investigators have 
determined vein graft stenoscs can be detected 
noninvasively with duplex scanning and that, as 
suggested by Szilagyi's work, most will be detected 
relatively early after operation. 5qa,15 In addition, it 
appears revision of duplex-detected graft stenoses 
results in excellent assisted primary patency 2°24 and 
overall higher assisted primary patency rates than can 
be obtained when graft revision is prompted only by 
clinical findings. 2531 As a result postoperative sur- 
veillance of infrainguinal vein grafts has become 
standard practice in most vascular surgical centers. 
Nevertheless ignificant questions remain regard- 
ing postoperative duplex surveillance ofinfrainguinal 
vein grafts. Among these questions is how long 
should duplex surveillance be continued after opera- 
tion? Mills et al. 17 reported that of 135 infrainguinal 
vein bypasses with a mean follow-up of 1 year, 33% 
within 3 months of operation had a duplex-detected 
flow abnormality defined as a peak systolic velocity 
greater than 150 cm/sec. In grafts with PSVs less than 
150 cm/sec the incidence of subsequent duplex- 
detected stenosis was so low the authors concluded 
that less intensive surveillance in this group was 
justified. However, the author concludes in the 
discussion after this report that, "The point of this 
study is that normal grafts do not get stenosis; they 
develop either from early appearing or preexisting 
areas of abnormality in the conduit." Taylor et al. 16 
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Fig. 3. High-grade intrinsic stenosis in proximal region 
of femoral to below-knee popliteal reverse saphenous vein 
graft. Lesion was first detected as PSV of 445 cm/sec in the 
proximal graft 14 months after initial bypass. Previous 
duplex evaluations at i week and 4, 7, and 10 months had 
shown PSVs between 96 and 178 cm/sec in this portion of 
graft. 
noted stenosis in 16% of 412 femorodistal grafts. 
More than 60% of stenoses were detected by 6 
months after operation, and no new stenoses were 
detected beyond 1 year, leading to the conclusion 
that, "if a policy of strict surveillance during the first 
year after operation is adhered to, further duplex 
surveillance is not justified." The implication from 
both of these studies is that "normal" early duplex 
surveillance xaminations have 100% specificity for 
excluding a missed early or later developing lesion 
that threatens graft patency. 
In our series of 447 infrainguinal reverse vein 
bypasses performed uring a 41/2-year period, 8.1% 
underwent revision because of a duplex surveillance 
abnormality. As in other studies l ,21'27 most vein graft 
revisions based on surveillance findings were per- 
formed for stenoses detected during the first postop- 
erative year. However, in 75% of our 36 patients the 
surveillance studies were initially "normal" in the 
same area that subsequently developed stenosis. 
Some grafts that subsequently required revision were 
without a detected focal stenosis (PSV ___ 200 cm/sec) 
or a mid-graft PSV -< 45 cm/sec on four or more 
serial examinations during the course of more than 
i year. Some of the delayed stenoses may represent 
lesions that were repeatedly missed. This finding does 
not detract from the observation that many lesions of 
sufficient severity to ultimately lead to graft throm- 
bosis 6,9,11 were detected, because surveillance was 
continued on a regular basis beyond 3 months after 
operation. In addition, in the absence of angio- 
graphic verification it is possible studies purporting 
to find no late graft lesions are missing lesions that are 
actually present but as of yet have not resulted in graft 
thrombosis. 
In this series 31% of the grafts were revised based 
on a mid-graft PSV _< 45 cm/sec rather than a high 
focal PSV. All of these "low flow" grafts had a signif- 
icant stenosis confirmed by angiography. In nine of 
the 11 grafts the stenosis was either in the inflow or 
outflow vessel or in the proximal portion of a graft 
with the proximal anastomosis to the deep femoral 
artery. This finding suggests duplex surveillance may 
lack sensitivity for directly detecting afocal stenosis in 
anatomically placed deep grafts or in inflow and out- 
flow vessels. Such stenoses would, however, be ex- 
pected to have an adverse ffect on graft patency. It is 
clear a mid-graft PSV - 45 cm/sec does not exclude a
significant graft stenosis 5'32 and that a mid-graft PSV 
_< 45 cm/sec does not prove the presence of a high- 
grade lesion) 3 Nevertheless we continue to regard 
low mid-graft PSVs as an important finding in our 
surveillance xaminations especially if higher mid- 
graft velocities were present previously. 
Because surveillance duplex examinations involve 
no patient risk and no perfect arterial substitute has 
yet been found, it is in our opinion medically justified 
to continue surveillance of vein grafts as long as the 
graft is patent and revision is practical. Presently, the 
cost-versus-benefit relationship for postoperative du- 
plex surveillance is unknown. Clearly, in this study, if 
duplex graft surveillance had been discontinued after 
1 year of "normal" duplex examination results, five 
lesions that potentially threatened graft patency 
would have been missed (Fig. 3). Discontinuation of 
duplex surveillance based on early normal examina- 
tion results will likely result in thrombosis of some 
vein grafts that could otherwise be salvaged with 
more prolonged surveillance. As long as resources 
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permit, we will continue to recommend to our 
patients regular postoperative duplex vein graft 
surveillance for the life of the vein graft. 
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DISCUSSION 
Dr. George Andros (Burbank, Calif.). President Elect 
Goldstone, members and guests. Dr. Passman and his 
colleagues from Portland question whether early graft 
surveillance fails to identify important latent graft defects 
that may result in late graft occlusion. They hypothesize 
surveillance should be continued for an extended period of 
time to detect late appearing lesions. 
The senior author of this paper is known in this society 
not to be without opinions in many areas, and I quote from 
the Yearbook of Vascular Surgery in 1994. "I do not think 
that one should be performing leg bypasses at all (sic) 
unless one is prepared to offer detailed post-operative 
duplex imaging." That is somewhat at odds with our 
dealings with insurance carriers in Southern California who 
will allow these procedures to be done but ultimately do 
not pay for any kind of surveillance. My first question 
therefore must be a financial one. How can we recommend 
extended color duplex graft surveillance when the sources 
of funds to pay for it are uncertain? The important issue 
here is detection of the failing graft, the link point between 
graft failure and graft patency. Dr. Passman has just 
summarized his data, so I will not repeat it except to say that 
I was a bit surprised about his comments on the increased 
difficulties with grafts arising from the deep femoral artery. 
The most important finding was that 31% of grafts had 
lesions detected 6 months after their implantation with 
previous tudies having been found to be normal. I should 
note that the authors perform acomplete surveillance of the 
graft on each occasion it is studied. 
If  you consider the standard graphical representation f 
a life patency table to be a phase display, a graft passes from 
the patent phase into the occluded phase through the 
failing graft phase. The failing graft period varies from a 
very short half-life with prosthetic grafts and homografts to 
a somewhat longer period of time with autogenous grafts. 
Additionally, the length of the failing graft period is 
dependent on the specific lesion that puts the graft at risk. 
Looked at from another point of view, a patency curve 
can be broken down into three component parts, each with 
a specific slope. Each phase corresponds to the pathophysi- 
ological process with the early phase accounting for graph 
occlusions resulting from errors in technique or judg- 
ment (selecting a bad vein). The middle phase is myo- 
intimal hyperplasia, and the late phase is progressive 
atherosclerosis. 
I find Dr. Passman's conclusions entirely plausible: 
stenotic lesions do develop late in the myointimal hyper- 
plasia phase, and these defects are discoverable by extend- 
ing graft surveillance. I wonder about the pathologic 
processes that cause these lesions. Could there be two 
classes of fibrostenosis, one of which began at the site of 
preexisting damage to the vein while it was in the venous 
circulation or was produced by minor trauma during the 
venous arterialization? Could there be a second class of 
myointimal fibrostenosis that appear later, that arises as 
vein valves fibrose or results from hemodynamic causes? 
What did you find when you repaired these lesions, and 
what methods did you use? 
The challenge in graft surveillance is obviously to find 
graft-threatening lesions and repair them before graft 
occlusion occurs. Your group has converted from graft 
surveillance at a single mid-graft point to a policy of 
complete graft inspection. Why the change? Did you find 
more lesions, and if so, what percentage of them did you 
repair to achieve the hoped-for objective of improving 
secondary patency? Your threshold criteria of a peak 
systolic velocity of 200 cm/sec are lower than advocated by 
other investigators. Are you finding more lesions that you 
choose not to repair? Do you think that all scanners would 
yield the same parameters, and if not, how would you 
standardize one machine against another? What sort of 
difference does it make in your surveillance if the graft is 
deep or superficial? What percentage of your graft occlu- 
sions occur while the patient is under surveillance? 
Dr. Marc A. Passman. The first question concerns our 
preferred schedule for the duplex surveillance examination. 
We prefer an initial postoperative evaluation and then 
evaluation at three monthly intervals for the first year and 
then every 6 months thereafter. We have not yet adopted 
some of the suggestions that there might be some types of 
stenoses that lend themselves tomore frequent surveillance. 
Based on this study, duplex surveillance should be contin- 
ued for the entire life of the graft. 
The second question concerns payment for duplex 
surveillance. We try to obtain reimbursement from the 
primary insurance carriers. When this is not possible, 
research grants cover the costs or the studies are performed 
without charge. 
Our patients are reasonably compliant with our rec- 
ommendations. However, being a referral institution, 
many come from far away, and this does make surveillance 
difficult in this subpopulation. 
The history of graft surveillance at Oregon is one that 
initially used a mid-graft peak systolic velocity of less than 
45 cm/sec as recommended by Bandyk. After 1990, with 
routine use of color flow for surveillance studies, the higher 
flow velocity criteria was added. This has worked well for 
detecting lesions with greater than 50% stenosis by 
subsequent angiography. 
We obtain an angiogram in all cases to confirm the 
presence of a stenosis. This is especially important in the 
group that has a low mid-graft velocity where a concomi- 
tant focal increase in peak systolic velocity was not found. 
Another question was directed at the occlusion of grafts 
while under surveillance. Of the 447 initial bypass opera- 
tions performed at our institution, 60 revisions were 
ultimately required. The 36 graft revisions in this study are 
a subpopulation that had had strict surveillance according 
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to the criteria discussed. The remaining patients include 
patients who presented with acute graft occlusion, which 
occurred in eight cases, and grafts with inadequate surveil- 
lance. At our institution the primary reason for inadequate 
surveillance is the great distances some patients must travel 
for follow-up surveillance xaminations. 
We did not address the pathologic characteristics of the 
lesions. Angiographically the lesions have the appearance of
those felt in other studies to be secondary to intimal 
hyperplasia. 
Regarding cost-effectiveness, it is clear duplex surveil- 
lance is medically effective. Cost-effectiveness has not been 
addressed. 
Dr. J. Dennis Baker (Los Angeles, Calif.). Across the 
country there are very wide variations as to what payments 
are made, especially for postoperative surveillance. Even 
within the Medicare program there is no uniformity from 
carrier to carrier. 
The specific question I have has to do with ABIs. You 
said only 30% of the cases had drops in ABIs, but what 
types of bypasses had these drops? 
Dr. Passman. About one-third of the grafts in this 
study were to a tibial artery. I don't believe there was any 
difference in the proportion of popliteal or tibial bypass 
that had a duplex abnormalic leading to revision not 
associated with a change in ABI. ABI alone is probably 
inadequate for optimal surveillance. 
Dr. William J. Quifiones-Baldrich (Los Angeles, 
Calif.). In the last 5 or 6 years we have been doing more and 
more very distal grafts that originate in the popliteal 
arteries. These are short grafts with limited outflow, and 
what we find is that in the initial duplex scan their velocities 
usually range somewhere between 25 and 40 cm/sec. 
In our experience when we did angiograms in those 
grafts where we could not find any specific area of stenoses 
by duplex scan but had relatively low velocities, no 
abnormalities were found. 
Have you had an opportunity to perform surveillance 
in these shorter grafts, and does the criteria of 45 cm/sec 
apply to them? 
Dr. Passman. The grafts primarily originated from the 
common femoral, superficial, or deep femoral artery. No 
grafts originating from the below-knee popliteal artery 
were in this study. So I cannot comment on whether our 
surveillance criteria will fit with that specific sort of graft. 
Dr. Gregory L. Moneta (Portland, Ore.). I agree with 
Dr. Quifiones-Baldrich. Grafts with limited outflow and/or 
to the pedal vessels often have mid-graft velocities less than 
45 cm/sec. We do generally not obtain angiograms inthose 
grafts solely for isolated low-flow velocities. 
Dr. Fred A. Weaver (Los Angeles, Calif.). I am 
interested in your routine use of angiography to confirm 
the stenoses. We have found that the angiogram often 
underestimates the graft stenosis, particularly if it is a 
weblike lesion, to the point where we no longer routinely 
obtain an angiogram to confirm a physiologic abnormality 
found by duplex scan. 
If you have a discrepancy between the duplex informa- 
tion and findings on your angiogram, which do you choose 
to believe, the angiogram or the duplex? 
Dr. Passman. You are correct, that in some cases, 
seemingly minimal esions on angiography are associated 
with surprisingly high flow velocities. A web-like lesion is 
probably better identified with duplex than angiography. If 
we find a high velocity and any suggestion on the 
angiogram ofa stenosis we will revise the graft. If however, 
a high velocity is not associated with any suspicion of a 
lesion on a high quality angiogram our tendency is to 
regard the duplex as a false positive study. Such false 
positive studies may be more likely in anatomically 
tunnelled grafts than in-situ bypasses. 
Dr. Joseph Mills (Tucson, Ariz.). I just wanted to 
make a few brief comments and ask two questions. This 
article actually was a response to a work that Dennis Ban- 
dyk and I did (J VASC Suv, c 1995;21:16-25). After we 
presented it last year Dr. Porter told me he did not believe 
it. The key issue was where do these lesions come from, 
and when do they occur? Our protocol was prospective. 
We started with intense early duplex scanning, and to get 
in our protocol the grafts had to have at least two duplex 
scans in the first 6 weeks. And actually, approximately three 
quarters of the grafts had three scans, and we were comfort- 
able at that point that if we could not find anything wrong 
on two or three scans, that that graft was in fact normal. 
In contrast, this study was retrospective in that only 
two thirds of the grafts had even one scan early on, but 
despite those caveats, if you look at the data I have an 
alternate interpretation. If you look at the number of grafts 
that required revision for abnormalities that were detected 
after 1 year, there were only five, and if you subtract he 
grafts that were revised before then, that gives you an 
incidence of de novo graft stenosis requiring repair of 1%. 
I would suggest that low incidence is not high enough 
to require the same intensity of surveillance for the entire 
duration of the graft and what we in fact recommended 
from our article was that you could stratify the grafts based 
on early scans. The scans that were abnormal early had a 
high incidence of progression, and those that were normal 
early had a low incidence of stenosis requiring repair, which 
in our series was 2%. So I think your data and ours actually 
agree. 
If you were to carry out the same intensity of 
surveillance after the first year, I did some calculations, if
you do approximately 100 grafts a year, as your group does, 
and have approximately a 10% revision rate, and approxi- 
mately 8% of the patients die per year, if you carry that out 
to the fifth year, you are going to be doing 1700 scans, if 
you do them every 3 months, which amounts to 7 scans per 
work day. So basically you would have a lab just scanning 
distal grafts all day long, which is absolutely impractical. 
So I think what I would ask you to do is reinterpret 
your data. Is there a way we can figure out which grafts 
require intensive surveillance and which ones we can back 
offon? What we suggested is that after you got to a year, 
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if things were normal, probably checking those grafts once 
or twice a year was sufficient, and you did not need to 
continue surveillance with the same intensity. 
Dr. Passman. In regards to Dr. Mills' calculations and 
estimations, we had very strict criteria for inclusion in this 
study and focused on patients who required revision and 
who had really had high quality surveillance. The 1% 
calculation (5/447) that you made assumes the same strict 
criteria for the entire bypass population. You should be 
more cautious in extrapolating data and in your underlying 
assumptions. 
In terms of which grafts to perform more or less 
intensive surveillance on, this study was not designed to 
look at that. This study was designed primarily to look at 
whether graft abnormalities by duplex occurred late, that is, 
beyond 6 months or even beyond 1 year, which I think we 
adequately showed. 
Dr. Moneta. Actually, Dr. Mills' memory has shifted 
a little bit. When I discussed his paper at the SVS meeting 
in June 1994 the only thing that I was concerned about was 
that in the manuscript that I had to review, it stated patients 
who had normal grafts initially would not require late 
surveillance. While I disagreed with this and still do, I agree 
with most everything else Dr. Mills said in his SVS paper. 
If the subsequent article for final publication in the journal 
has been revised, I think that reflects well on Dr. Mills' 
reasoning and probably very well on the review process of 
the JOURNAL. 
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